Dianthus Therapeutics | MGTA - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Celltrion KRW 779M 157.66M 2026-03
Dianthus Therapeutics USD 6.26M 2.61M 2026-03
IQVIA Holdings USD 7M 3M 2026-06
Kangmei Pharma CNY 2.44M 635.78K 2026-03
Knight Therapeutics CAD 2.46M 498K 2024-09
Laboratorios Farma EUR 139K 42K 2025-06
Medical Developments International AUD 174K 31K 2024-12
Moderna USD 72M 2M 2026-03
Pharma Mar EUR 1.63M 3.17M 2025-12
Qiagen NV USD 10.56M 9.44M 2026-03
Revvity USD 6.3M 552K 2026-03
Sartorius EUR 14.8M 5.3M 2026-06
Tectonic Therapeutic USD 1.74M 217K 2024-12
Tilray USD 12.83M 20.19M 2024-05
Xeris Pharmaceuticals USD 1.2M 44K 2026-03
Zealand Pharma A/S 74M 28.41M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M 2026-03